These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6851863)

  • 1. 1983 perspectives on the pharmacotherapy of opiate addiction.
    Cushman P
    Drug Alcohol Depend; 1983 Feb; 11(1):87-93. PubMed ID: 6851863
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment options for opiate addiction.
    J Ky Med Assoc; 2004 May; 102(5):221-4. PubMed ID: 15152448
    [No Abstract]   [Full Text] [Related]  

  • 3. Treating opiate addiction, Part I. Detoxification and maintenance.
    Harv Ment Health Lett; 2004 Dec; 21(6):4-6. PubMed ID: 15717347
    [No Abstract]   [Full Text] [Related]  

  • 4. Buprenorphine/naloxone versus methadone in opioid dependence: a longitudinal survey.
    Curcio F; Franco T; Topa M; Baldassarre C;
    Eur Rev Med Pharmacol Sci; 2011 Aug; 15(8):871-4. PubMed ID: 21845796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medication-assisted recovery from opioid addiction: historical and contemporary perspectives.
    White WL
    J Addict Dis; 2012; 31(3):199-206. PubMed ID: 22873182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Commentary on Hser et al. (2014): to retain or not to retain-open questions in opioid maintenance therapy.
    Soyka M; Hillemacher T
    Addiction; 2014 Jan; 109(1):88-9. PubMed ID: 24438113
    [No Abstract]   [Full Text] [Related]  

  • 7. Readiness and recovery: Transferring between methadone and buprenorphine/naloxone for the treatment of opioid use disorder.
    Bishop B; Gilmour J; Deering D
    Int J Ment Health Nurs; 2019 Feb; 28(1):226-236. PubMed ID: 30019812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid addicted buprenorphine injectors: drug use during and after 12-weeks of buprenorphine-naloxone or methadone in the Republic of Georgia.
    Piralishvili G; Otiashvili D; Sikharulidze Z; Kamkamidze G; Poole S; Woody GE
    J Subst Abuse Treat; 2015 Mar; 50():32-7. PubMed ID: 25456093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-patient detoxification procedures, treatment retention, and post-treatment opiate use: comparison of lofexidine + naloxone, lofexidine + placebo, and methadone.
    McCambridge J; Gossop M; Beswick T; Best D; Bearn J; Rees S; Strang J
    Drug Alcohol Depend; 2007 Apr; 88(1):91-5. PubMed ID: 17064857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methadone Medical Maintenance: An Early 21st-Century Perspective.
    Novick DM; Salsitz EA; Joseph H; Kreek MJ
    J Addict Dis; 2015; 34(2-3):226-37. PubMed ID: 26110221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Buprenorphine/naloxone versus methadone and lofexidine in community stabilisation and detoxification: A randomised controlled trial of low dose short-term opiate-dependent individuals.
    Law FD; Diaper AM; Melichar JK; Coulton S; Nutt DJ; Myles JS
    J Psychopharmacol; 2017 Aug; 31(8):1046-1055. PubMed ID: 28631527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale for maintenance pharmacotherapy of opiate dependence.
    Kreek MJ
    Res Publ Assoc Res Nerv Ment Dis; 1992; 70():205-30. PubMed ID: 1346939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does prescribing for opiate addiction change after national guidelines? Methadone and buprenorphine prescribing to opiate addicts by general practitioners and hospital doctors in England, 1995-2005.
    Strang J; Manning V; Mayet S; Ridge G; Best D; Sheridan J
    Addiction; 2007 May; 102(5):761-70. PubMed ID: 17506153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use and misuse of opioid agonists in opioid addiction.
    Modesto-Lowe V; Swiezbin K; Chaplin M; Hoefer G
    Cleve Clin J Med; 2017 May; 84(5):377-384. PubMed ID: 28530896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use and misuse of opioid replacement therapies: a Queensland study.
    Smirnov A; Kemp R
    Subst Use Misuse; 2012 Jan; 47(1):78-85. PubMed ID: 22216993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical utility of clonidine in opiate withdrawal: a study of 100 patients.
    Gold MS; Kleber HD
    Prog Clin Biol Res; 1981; 71():299-306. PubMed ID: 6276899
    [No Abstract]   [Full Text] [Related]  

  • 17. The acceptability of combined methadone-naloxone treatment: Consumer and provider views on the potential utility of methadone-naloxone.
    Shearer J; Mammen K; Bell J
    Drug Alcohol Rev; 2010 Mar; 29(2):138-43. PubMed ID: 20447220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of Opioid Overdose.
    Babu KM; Brent J; Juurlink DN
    N Engl J Med; 2019 Jun; 380(23):2246-2255. PubMed ID: 31167053
    [No Abstract]   [Full Text] [Related]  

  • 19. Opioid Use Disorder and Incarceration - Hope for Ensuring the Continuity of Treatment.
    Binswanger IA
    N Engl J Med; 2019 Mar; 380(13):1193-1195. PubMed ID: 30811904
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacotherapy of Opioid Addiction: "Putting a Real Face on a False Demon".
    Salsitz E; Wiegand T
    J Med Toxicol; 2016 Mar; 12(1):58-63. PubMed ID: 26567033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.